INCIDENCE AND RISK FACTORS OF LYMPHEDEMA AFTER REGIONAL TREATMENT OF BREAST CANCER
Keywords:Axillary lymph node dissection, Breast cancer, Lymphedema, Modified radical mastectomy, Wide local excision
Lymphedema is a limb swelling caused by the accumulation of protein- rich fluid in the body tissues secondary to the disturbance of lymphatic drainage. Moreover, the most common risk factor is the regional treatments for breast cancer.
To find out the incidence of lymphedema and the risk factors for development of lymphedema after wide local excision, modified radical mastectomy, axillary lymph node dissection and radiotherapy in patients with breast cancer.
Patients and Methods
This retrospective study of 288 patients with breast cancer collected from Hiwa Oncology Hospital, Zhianawa Cancer Centre and Breast Diseases Center in Sulaimani Governorate who underwent surgery, chemotherapy and/or radiotherapy during 1st January 2016 to 31st December 2017. All patients had been followed up for duration of (6 - 36) months. Data were collected from each patient. Breast ultrasonography, mammography, fine needle aspiration cytology, and tru-cut biopsy were collected. The arm circumference of the affected-side was measured ten centimeters above and below supracondylar region and the diagnosis of lymphedema was considered if the arm circumference differences were two centimeters or higher.
The mean ± standard deviation of age (year) was 48.6 ± 10.8 (ranged from 23 to 84) and the majority of the participants were females, with a male to female ratio of (0.03). 74 (25.7%) of the patients were developed lymphedema, 17% of them had lymphedema after surgery, 6.9% of them had lymphedema after radiotherapy and 1.7% of them had lymphedema after both surgery and radiotherapy.
The types of treatment for breast cancer will affect the occurrence of lymphedema especially if the treatment involves the disturbance of lymphatic drainages and there was a statistically significant association with the lymphedema.
- Williams NS, Bulstrode CJK, O'Connell PR. Bailey & Love’s short practice of surgery. Florida: Taylor & Francis Group; 2013.
- DiSipio T, Rye S, Newman B, Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 2013; 14(6):500-15.
- Warren AG, Brorson H, Borud LJ, Slavin SA. Lymphedema: a comprehensive review. Ann Plast Surg. 2007;59(4):464-72.
- American Cancer Society. Cancer Facts & Figures 2009. Atlanta: American Cancer Society; 2009.
- Armer JM. The problem of post-breast cancer lymphedema: impact and measurement issues. Cancer Invest. 2005;23(1):76-83.
- Rourke LL, Hunt KK, Cormier JN. Breast cancer and lymphedema: a current overview for the healthcare provider. Womens Health (Lond). 2010;6(3):399-406.
- Petrek JA, Heelan MC. Incidence of breast carcinoma-related lymphedema. Cancer. 1998; 83(12 Suppl American):2776-81.
- Herd-Smith A, Russo A, Muraca MG, Del Turco MR, Cardona G. Prognostic factors for lymphedema after primary treatment of breast carcinoma. Cancer. 2001;92(7):1783-7.
- Park JH, Lee WH, Chung HS. Incidence and risk factors of breast cancer lymphoedema. J Clin Nurs. 2008;17(11):1450-9.
- Clark B, Sitzia J, Harlow W. Incidence and risk of arm oedema following treatment for breast cancer: a three-year follow-up study. QJM. 2005;98(5):343-8.
- Pain SJ, Purushotham AD. Lymphoedema following surgery for breast cancer. Br J Surg. 2000;87(9):1128-41.
- Muscari E. Lymphedema: responding to our patients' needs. Oncol Nurs Forum. 2004;31(5):905-12.
- Armer JM, Stewart BR. A comparison of four diagnostic criteria for lymphedema in a post-breast cancer population. Lymphat Res Biol. 2005;3(4):208-17.
- Ward L. Is BIS ready for prime time as the gold standard measure? J. Lymphoedema. 2009;4(2):52–6.
- Witte CL, Witte MH. Diagnostic and interventional imaging of lymphatic disorders. Int Angiol. 1999; 18(1):25-30.
- Rourke LL, Hunt KK, Cormier JN. Breast cancer and lymphedema: a current overview for the healthcare provider. Womens Health (Lond). 2010 May;6(3):399-406.
- Ahmed M, Rubio IT, Kovacs T, Klimberg VS, Douek M. Systematic review of axillary reverse mapping in breast cancer. Br J Surg. 2016;103(3):170-8.
Morcos BB, Al Ahmad F, Anabtawi I, Abu Sba AM, Shabani H, Yaseen R. Lymphedema. A significant health problem for women with breast cancer in Jordan. Saudi Med J. 2013;34(1):62-6.
- Goker M, Devoogdt N, Van de Putte G, Schobbens JC, Vlasselaer J, Van den Broecke R, et al. Systematic review of breast cancer related lymphoedema: making a balanced decision to perform an axillary clearance. Facts Views Vis Obgyn. 2013; 5(2):106-15.
- Kotepui M, Chupeerach C. Age distribution of breast cancer from a Thailand population- based cancer registry. Asian Pac J Cancer Prev. 2013;14(6):3815-7.
- Brophy JT, Keith MM, Watterson A, Park R, Gilbertson M, Maticka-Tyndale E, et al. Breast cancer risk in relation to occupations with exposure to carcinogens and endocrine disruptors: a Canadian case-control study. Environ Health. 2012; 11:87.
- McLaughlin SA, Wright MJ, Morris KT, Giron GL, Sampson MR, Brockway JP, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol. 2008; 26(32):5213-9.
- Saood MJ, Abdulla MH, Tawfiq NR. Lymphedema following axillary lymph node sampling versus axillary lymph node dissection for patients with breast carcinoma in Al-Karama Teaching Hospital, Iraq. Int Surg J. 2017;4(8):2409-12.
Copyright (c) 2020 Hawar Hasan Ali Ghalib, Dara Ahmed Mohammed, Kanar Abubakr Xaznazdr, and Khalid Mustafa Abdullah
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.